Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Itaú Unibanco
ITUB
$93.2B
| $80.5M | 0.06% |
21,303,321
-1,197,604
| -5% | -$5.32M |
|
152
Winnebago Industries
WGO
$881M
| $80.2M | 0.06% |
1,651,821
-16,915
| -1% | -$874K |
|
153
West Pharmaceutical
WST
$24.5B
| $77.7M | 0.06% |
256,870
-8,007
| -3% | -$2.61M |
|
154
Carrier Global
CARR
$51.7B
| $75.8M | 0.05% |
2,124,741
-79,707
| -4% | -$3.13M |
|
155
East-West Bancorp
EWBC
$18B
| $75.7M | 0.05% |
1,167,779
+40,123
| +4% | +$2.88M |
|
156
Lazard
LAZ
$4.16B
| $75.4M | 0.05% |
2,325,250
+318,065
| +16% | +$10.7M |
|
157
Bio-Rad Laboratories Class A
BIO
$8.91B
| $74.4M | 0.05% |
150,258
+10,258
| +7% | +$5.34M |
|
|
PDCE
158
DELISTED
PDC Energy, Inc.
PDCE
| $73.9M | 0.05% |
1,199,874
-316,800
| -21% | -$23M |
|
159
Toro Company
TTC
$9.02B
| $73.7M | 0.05% |
972,969
-14,440
| -1% | -$1.17M |
|
160
Otis Worldwide
OTIS
$27.4B
| $73.3M | 0.05% |
1,036,845
-40,283
| -4% | -$2.97M |
|
|
AZPN
161
DELISTED
Aspen Technology Inc
AZPN
| $73.2M | 0.05% |
+398,580
| New | +$70.9M |
|
162
Semtech
SMTC
$11B
| $71.8M | 0.05% |
1,305,814
+28,674
| +2% | +$1.73M |
|
163
Littelfuse
LFUS
$11.2B
| $71.2M | 0.05% |
280,188
-7,510
| -3% | -$1.88M |
|
164
KB Home
KBH
$3.42B
| $69.3M | 0.05% |
2,434,703
+22,434
| +0.9% | +$716K |
|
165
Azenta
AZTA
$1.35B
| $68.8M | 0.05% |
953,674
+24,135
| +3% | +$1.8M |
|
166
Chemed
CHE
$7.14B
| $68.4M | 0.05% |
145,731
-2,731
| -2% | -$1.33M |
|
|
BECN
167
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $67.9M | 0.05% |
1,321,869
-29,445
| -2% | -$1.73M |
|
168
Helen of Troy
HELE
$682M
| $67.5M | 0.05% |
415,315
-10,785
| -3% | -$2.03M |
|
169
Global Payments
GPN
$23.4B
| $67.4M | 0.05% |
609,540
-17,568
| -3% | -$2.22M |
|
170
Teledyne Technologies
TDY
$30.7B
| $65.4M | 0.05% |
174,258
-3,483
| -2% | -$1.45M |
|
|
PC
171
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
| $65.4M | 0.05% |
8,097,644
+1,022,542
| +14% | +$8.25M |
|
172
Intel
INTC
$458B
| $65M | 0.05% |
1,738,775
-40,744
| -2% | -$1.76M |
|
173
Qorvo
QRVO
$7.83B
| $64.9M | 0.05% |
688,591
+375
| +0.1% | +$40.4K |
|
174
Vishay Intertechnology
VSH
$5.38B
| $64.3M | 0.05% |
3,607,553
-96,689
| -3% | -$1.84M |
|
175
Qualcomm
QCOM
$158B
| $64.2M | 0.05% |
502,289
+14,331
| +3% | +$1.95M |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.